4.5 Article

LRRK2 and mitochondria: Recent advances and current views

Journal

BRAIN RESEARCH
Volume 1702, Issue -, Pages 96-104

Publisher

ELSEVIER
DOI: 10.1016/j.brainres.2018.06.010

Keywords

Parkinson's disease; LRRK2; Mitochondrial dysfunction; Mitochondrial dynamics; Mitophagy; Trafficking

Categories

Funding

  1. National Institute of Neurological Disorders and Stroke (NINDS) [NS098393]
  2. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS098393] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene account for most common causes of familial and sporadic Parkinson's disease (PD) and are one of the strongest genetic risk factors in sporadic PD. Pathways implicated in LRRK2-dependent neurodegeneration include cytoskeletal dynamics, vesicular trafficking, autophagy, mitochondria, and calcium homeostasis. However, the exact molecular mechanisms still need to be elucidated. Both genetic and environmental causes of PD have highlighted the importance of mitochondrial dysfunction in the pathogenesis of PD. Mitochondrial impairment has been observed in fibroblasts and iPSC-derived neural cells from PD patients with LRRK2 mutations, and LRRK2 has been shown to localize to mitochondria and to regulate its function. In this review we discuss recent discoveries relating to LRRK2 mutations and mitochondrial dysfunction. (C) 2018 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available